2020–2021 BCSC Basic and Clinical Science Course™
Chapter 12: Medical Management of Glaucoma and Ocular Hypertension
General Approach to Medical Treatment
Many glaucoma medications are available as generic drugs. Although the generic agents are required to be chemically or biologically equivalent to the brand-name product, in some cases there may be differences in formulation that could potentially alter a drug’s effect. Brimonidine and bimatoprost, for example, are available in generic formulations that differ in concentration of the active ingredients from the brand-name products (see Table 12-2). The use of lower-cost generic medications has been shown to improve patient adherence to medication regimens.
Excerpted from BCSC 2020-2021 series: Section 10 - Glaucoma. For more information and to purchase the entire series, please visit https://www.aao.org/bcsc.